Strong PD-L1 Affect Clinical Outcomes in Advanced NSCLC Treated with Third-Generation EGFR-TKIs
Future oncology (London, England)（2024）
关键词
EGFR mutations,non-small cell lung cancer,programmed death ligand 1,tyrosine kinase inhibitors
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要